FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
Today, the FDA approved a novel treatment for hemophilia A or B, with or without factor VIII or IX inhibitors (neutralizing antibodies).
Related Articles
FDA/The Osteosarcoma Institute (OSI) Workshop
Meeting information for FDA/The Osteosarcoma Institute (OSI) Workshop
FDA Releases New Tool for Toxicity Screening of Chemicals in Food
FDA Releases New Tool for Toxicity Screening of Chemicals in Food
Hillside Orchard Farms Recalls Various Fruit Breads & Fritters Due to Undeclared Egg
Tiger GA – July 28, 2025 – Hillside Orchard Farms is recalling various flavors of their 23oz Fruit Breads & 7.5 oz Fritters due to…
Hiding in Plain Sight: 7-OH Products
The time to act is now. We can and must prevent the next wave of the opioid crisis.
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients
Tropicale Foods Recalls Certain Helados Mexico and La Michoacana Products Due to Undeclared Milk
Tropicale Foods of Ontario, CA is recalling certain Helados Mexico and La Michoacana products with specific best by dates, as detailed below because these products…
Ethicon Endo-Surgery, LLC Issues Correction for Endopath Echelon
Ethicon Endo-Surgery is correcting the Endopath Echelon due to a potential surgical lockout that stops cutting or stapling and requires extra removal steps.